Paper856462
Plasma pharmacokinetics of adriamycin and its metabolites in humans with normal hepatic and renal function.
Benjamin RS and 2 others. Cancer Res, 1977. Cited by 243 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Plasma pharmacokinetics of adriamycin and its metabolites in humans with normal hepatic and renal function. Papers, record 856462. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/856462
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Plasma pharmacokinetics of adriamycin and its metabolites in humans with normal hepatic and renal function.
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Doxorubicin | Major topic |
| Half-Life | |
| Humans | |
| Kidney | |
| Liver | |
| Neoplasms |
Source PubMed
Cited by65
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 243 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38609583 | Combination of Doxorubicin and Antiangiogenic Agents in Drug-Eluting Beads: In Vitro Loading and Release Dynamics in View of a Novel Therapeutic Approach for Hepatocellular Carcinoma. | Cardiovasc Intervent Radiol | 2024 | https://conductscience.org/library/papers/38609583 | PubMed |
| 33404976 | Multiscale and Translational Quantitative Systems Toxicology, Pharmacokinetic-Toxicodynamic Modeling Analysis for Assessment of Doxorubicin-Induced Cardiotoxicity. | AAPS J | 2021 | https://conductscience.org/library/papers/33404976 | PubMed |
| 30221011 | Randomized study of doxorubicin-based chemotherapy regimens, with and without sildenafil, with analysis of intermediate cardiac markers. | Cardiooncology | 2018 | https://conductscience.org/library/papers/30221011 | PubMed |
| 27007464 | Nodal expression in triple-negative breast cancer: Cellular effects of its inhibition following doxorubicin treatment. | Cell Cycle | 2016 | https://conductscience.org/library/papers/27007464 | PubMed |
| 25909710 | Plasma TNF-α and Soluble TNF Receptor Levels after Doxorubicin with or without Co-Administration of Mesna-A Randomized, Cross-Over Clinical Study. | PLoS One | 2015 | https://conductscience.org/library/papers/25909710 | PubMed |
| 22964943 | A mechanistic study of the effect of doxorubicin/adriamycin on the estrogen response in a breast cancer model. | Oncology | 2012 | https://conductscience.org/library/papers/22964943 | PubMed |
| 20653682 | Failure of liver function tests in predicting drug clearance of chemotherapeutic agents in a patient who had recovered from hepatic congestion. | Br J Clin Pharmacol | 2010 | https://conductscience.org/library/papers/20653682 | PubMed |
| 18749444 | Cardiotoxic effects of anthracyclines. | West J Med | 1983 | https://conductscience.org/library/papers/18749444 | PubMed |
| 15656694 | Interactions between antiretrovirals and antineoplastic drug therapy. | Clin Pharmacokinet | 2005 | https://conductscience.org/library/papers/15656694 | PubMed |
| 8738403 | Intravesical suramin: a novel agent for the treatment of superficial transitional-cell carcinoma of the bladder. | World J Urol | 1996 | https://conductscience.org/library/papers/8738403 | PubMed |
| 8453681 | Prochlorperazine as a doxorubicin-efflux blocker: phase I clinical and pharmacokinetics studies. | Cancer Chemother Pharmacol | 1993 | https://conductscience.org/library/papers/8453681 | PubMed |
| 8269583 | Effects of the methoxymorpholino derivative of doxorubicin and its bioactivated form versus doxorubicin on human leukemia and lymphoma cell lines and normal bone marrow. | Cancer Chemother Pharmacol | 1993 | https://conductscience.org/library/papers/8269583 | PubMed |
| 8137454 | Pharmacokinetics of doxorubicin and its active metabolite in patients with normal renal function and in patients on hemodialysis. | Cancer Chemother Pharmacol | 1994 | https://conductscience.org/library/papers/8137454 | PubMed |
| 7599068 | An evaluation of hepatic extraction and clearance of doxorubicin. | Br J Cancer | 1995 | https://conductscience.org/library/papers/7599068 | PubMed |
| 7397946 | Influence of tumor on adriamycin concentration in blood cells. | Cancer Chemother Pharmacol | 1980 | https://conductscience.org/library/papers/7397946 | PubMed |
| 7350193 | Enzymatic defenses of the mouse heart against reactive oxygen metabolites: alterations produced by doxorubicin. | J Clin Invest | 1980 | https://conductscience.org/library/papers/7350193 | PubMed |
| 7287901 | Prevention of doxorubicin cardiac toxicity in the mouse by N-acetylcysteine. | J Clin Invest | 1981 | https://conductscience.org/library/papers/7287901 | PubMed |
| 7274305 | Differential adriamycin distribution to blood components. | Eur J Drug Metab Pharmacokinet | 1981 | https://conductscience.org/library/papers/7274305 | PubMed |
| 7206588 | [The pharmacokinetics of adriamycin and adriamycin-metabolites (author's transl)]. | Klin Wochenschr | 1980 | https://conductscience.org/library/papers/7206588 | PubMed |
| 7059411 | Dosage adjustment in renal insufficiency. | Br J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/7059411 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/856462
GET https://conductscience.org/api/papers/v1/856462/cited_by?page=2